Vascular Dysfunction and Metabolic Parameters in Polycystic Ovary Syndrome
نویسندگان
چکیده
منابع مشابه
Polycystic ovary syndrome: implications of metabolic dysfunction.
OBJECTIVE To determine the prevalence of metabolic syndrome (MS) and its clinical interrelations in polycystic ovary syndrome (PCOS). METHODS This was a cross-sectional, prospective study with 100 patients with diagnosed PCOS based on the consensus of Rotterdam (2003). We investigated the interrelationships of MS, with intrinsic PCOS data. Dermatological profile was analyzed, in addition to a...
متن کاملMetabolic Syndrome in Patients with Polycystic Ovary Syndrome in Iran
Background The prevalence of metabolic syndrome (MetS) in polycystic ovary syndrome (PCOS) has been studied in different populations, but their results were so controversial regarding Iranian women. These controversial data indicated the need for more investigation of MetS characteristics in PCOS patients in our population. So this study aimed to evaluate the clinical and laboratory characteris...
متن کاملMetabolic dysfunction in obese Hispanic women with polycystic ovary syndrome.
STUDY QUESTION Are certain ethnic groups with polycystic ovary syndrome (PCOS) at increased risk of metabolic disorders? SUMMARY ANSWER Obese Hispanic women with PCOS are at increased risk of metabolic disorders compared with age- and BMI-matched obese non-Hispanic white women with PCOS in the USA. WHAT IS KNOWN ALREADY Ethnic differences in body composition and metabolic risk are well esta...
متن کاملPolycystic ovary syndrome and the metabolic syndrome.
Polycystic ovary syndrome (PCOS) is a common endocrinological disorder in female reproductive age. Insulin resistance (IR) and compensatory hyperinsulinemia seem to be the main pathophysiologies of this syndrome. Therefore, PCOS is at risk for abnormal glucose tolerance, dyslipidemia, central obesity and hypertension. Also, plasminogen activator-inhibitor-1 (PAL-1), hemostatic factor and C-reac...
متن کاملPolycystic Ovary Syndrome and the Metabolic Syndrome
Diabetologists have long recognized the comorbid diseases of obesity, hypertension, and hyperlipidemia in their type 2 diabetic patients, and the necessity of treating these conditions in order to improve outcomes. Cardiovascular disease (CVD) is the number-one cause of death among patients with diabetes, and its prevention is at the forefront of modern diabetes care. The clustering of insulin ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Clinical Endocrinology & Metabolism
سال: 2005
ISSN: 0021-972X,1945-7197
DOI: 10.1210/jc.2004-1487